Teriparatide, bisphosphonates and HRT to osteoporosis of woman

被引：0
|
作者：
Bazarra-Fernandez, A. [1 ]
Bazarra-Castro, M. A. [1 ]
机构：
[1] Med Santiago Univ, Santiago, Spain
来源：
OSTEOPOROSIS INTERNATIONAL | 2006年 / 17卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：419 / 419
页数：1
相关论文
共 50 条
  • [11] The effects of switching daily teriparatide to oral bisphosphonates or denosumab in patients with primary osteoporosis
    Kosuke Ebina
    Jun Hashimoto
    Masafumi Kashii
    Makoto Hirao
    Shoichi Kaneshiro
    Takaaki Noguchi
    Yasunori Tsukamoto
    Hideki Yoshikawa
    Journal of Bone and Mineral Metabolism, 2017, 35 : 91 - 98
  • [12] Head-to-head comparisons of bisphosphonates and teriparatide in osteoporosis: a meta-analysis
    Liu, Chun-Lin
    Lee, Han-Chung
    Chen, Chun-Chung
    Cho, Der-Yang
    CLINICAL AND INVESTIGATIVE MEDICINE, 2017, 40 (03): : E146 - E157
  • [13] Bisphosphonates Maintain BMD After Sequential Teriparatide and Denosumab in Premenopausal Women with Idiopathic Osteoporosis
    Kamanda-Kosseh, Mafo
    Shiau, Stephanie
    Agarwal, Sanchita
    Kondapalli, Ananya
    Colon, Ivelisse
    Kil, Nayoung
    Bucovsky, Mariana
    Lappe, Joan M.
    Stubby, Julie
    Shane, Elizabeth
    Cohen, Adi
    JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2024, 110 (03) : e791 - e801
  • [14] Switching to Denosumab or Bisphosphonates After Completion of Teriparatide Treatment in Women With Severe Postmenopausal Osteoporosis
    Kocjan, Tomaz
    Rajic, Antonela Sabati
    Janez, Andrej
    Vidmar, Gaj
    Orehek, Nina
    Marc, Janja
    Ostanek, Barbara
    ENDOCRINE PRACTICE, 2021, 27 (09) : 941 - 947
  • [15] HRT AND OSTEOPOROSIS
    BARLOW, DH
    BAILLIERES CLINICAL RHEUMATOLOGY, 1993, 7 (03): : 535 - 548
  • [16] OSTEOPOROSIS AND HRT
    MILNER, M
    HARRISON, RF
    IRISH MEDICAL JOURNAL, 1991, 84 (01) : 2 - 3
  • [17] HRT AND OSTEOPOROSIS
    COMPSTON, JE
    BRITISH MEDICAL BULLETIN, 1992, 48 (02) : 309 - 344
  • [18] Bisphosphonates Maintain BMD after Sequential Teriparatide and Denosumab in Premenopausal Women with Idiopathic Osteoporosis (PremenIOP)
    Kamanda-Kosseh, Mafo
    Shiau, Stephanie
    Agarwal, Sanchita
    Kondapalli, Ananya
    Colon, Ivelisse
    Kil, Nayoung
    Bucovsky, Mariana
    Recker, Robert
    Lappe, Joan
    Stubby, Julie
    Shane, Elizabeth
    Cohen, Adi
    JOURNAL OF BONE AND MINERAL RESEARCH, 2023, 38 : 4 - 4
  • [19] Denosumab, teriparatide and bisphosphonates for glucocorticoid-induced osteoporosis: a Bayesian network meta-analysis
    Dong, Liang
    Jiang, Lianghai
    Xu, Zhengwei
    Zhang, Xiaobo
    FRONTIERS IN PHARMACOLOGY, 2024, 15
  • [20] BISPHOSPHONATES FOR OSTEOPOROSIS TREATMENT: A COST-EFFECTIVENESS ANALYSIS IN VIETNAMESE WOMAN
    Pham, N. H.
    Nguyen, T. B.
    Le, H. P.
    Pham, D. T.
    Ho-Pham, L. T.
    Duong, T. D.
    Nguyen, T., V
    VALUE IN HEALTH, 2017, 20 (09) : A535 - A535
12345